6hon MSN
Nelly Korda (USA) 430.29 2. (2) Lydia Ko (New Zealand) 285.25 3. (3) Ruoning Yin (China PR) 251.03 4. (4) Atthaya Thitikul (Thailand) 236.76 5. (5) Lilia Vu (USA) 219.07 6. (6) Hannah Green (Australia ...
DeepSeek’s announcement last month that it has developed advanced AI with less advanced and fewer chips has emboldened ...
Scores from the LPGA Tour Founders Cup presented by U.S. Virgin Islands on Sunday1Georgia Hall (Great Britain)758Nicole Broch Estrup (Denmark)744Weiwei Zhang (China PR)72Lauren Stephenson (USA)74Karis ...
Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...
Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.
The bento makers have been in business for more than 100 years. They jointly opened the pop-up store and sell six types of ekiben, including rice with Swiss beef, miso katsuju, or pork cutlet with ...
The battle to drastically reduce, if not totally eradicate, dengue cases must involve yearlong efforts. It cannot be a ...
Kim led by four after the first round and moved to 10-under 134 at the halfway mark of the LPGA's season opener. Linn Grant of Sweden shot a 67 at Lake Nona Golf & Country Club and now stands at 7 ...
South Korea's Kim A-lim heads into the weekend at the LPGA's season-opening Tournament of Champions in Orlando with a three ...
Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.
Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. | Takeda is promoting U.S. chief Julie Kim ...
Takeda Pharmaceutical's strong earnings, dividends, and strategic moves make it an appealing investment despite US policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results